Teikoku Pharma Usa, Inc.

Birch Point Medical, Inc.

Verde Environmental Technologies, Inc.

Travanti Pharma Inc.

Teva Pharmaceuticals International Gmbh

Nupathe Inc.

Other

International Technidyne Corporation

Carter R Anderson

Russell L Morris

Robert Cohen

William V Fowler

Clayton Anderson

Walter L Sembrowich

Terri Sebree

Lori A Grace

William R Kennedy

Kee Van Sin

James D Kurkowski

Kathleen A Eischen

David T Giddings

Robbi T Thompson

Clayton J Anderson

The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.

Abuse potential reduction in abusable substance dosage form

A disposable skin-worn device for the transdermal delivery at least one dose of charged therapeutic substances, including granisetron, by iontophoresis, the device comprising a donor reservoir containing an amount of a therapeutic substance to be delivered transdermally by iontophoresis, a counter reservoir, a source of electric power connected in a circuit between the donor reservoir and the counter reservoir and a control system for controlling current flow in the circuit to enable at least one dose of the therapeutic substance to be delivered transdermally by iontophoresis and wherein the control system includes a control element selected from the group consisting of a sensor activated by an external signal and a switch.

Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis

An integrated iontophoresis skin-worn patch and method for delivering a therapeutically effective amount of a corticosteroid drug compound in a systemically-safe and skin-safe manner for site-specific treatment of inflammation pain is disclosed.

Transdermal methods and systems for the delivery of corticosteroid compounds

Devices for use in the disposal of pharmaceutical compositions are provided. Aspects of the devices include: a support having a surface; an activated carbon layer present on the surface; and an adhesive for stably associating a pharmaceutical composition with the activated carbon layer upon application of the pharmaceutical composition to the activated carbon layer. Also provided are methods of using the devices and kits containing the devices.

Transdermal patch disposal system

Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.

Transdermal methods and systems for the delivery of anti-migraine compounds

General medication disposal systems are provided. Aspects of the systems include devices having a sealable container dimensioned to accommodate a pharmaceutical composition; and an amount of an inactivating substance, e.g., granulated or pelletized activated carbon, present inside of the sealable container. Aspects of the invention further include methods of making and using the systems, as well as kits comprising the devices of the system.

General medication disposal system

The potential for environmental release of unused and expired medications is reduced by the provision of a system and method for combining the unused or expired medication with an amount of activated carbon as part of a disposal procedure.

Medication disposal system

Growing community of inventors

Inver Grove Heights, MN, United States of America

Carter R Anderson